Drug Firms Battle In Del., Calif. Over Shared LLC, $60M IP
By Jeff Montgomery ( April 29, 2016, 10:34 PM EDT) -- Pharmaceutical developer Syntrix Biosystems Inc. on Friday asked the Delaware Chancery Court to dissolve a company it formed with PharmaInvest LLC to develop a drug for autoimmune diseases, saying PharmaInvest failed to make required investments and paralyzed the business and a $60 million intellectual property right with an injunction....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.